Related Experiment Video

Updated: Apr 21, 2026

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
09:36

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

10.9K

MTSS1 suppresses cell migration and invasion by targeting CTTN in glioblastoma

Shoudan Zhang1, Qigui Qi

  • 1Department of Neurosurgery, The First Affiliated Hospital of Liaoning Medical University, Jinzhou, 121000, China.

Journal of Neuro-Oncology
|November 12, 2014
PubMed

Insights

Metastasis suppressor 1 (MTSS1) acts as a tumor suppressor in glioblastoma (GBM). Low MTSS1 expression correlates with poor GBM patient outcomes and inhibits tumor cell migration and invasion by reducing CTTN expression.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Cancer research

Background:

  • Glioblastomas (GBMs) are aggressive primary brain tumors.
  • Metastasis suppressor 1 (MTSS1) is implicated in cancer metastasis and acts as a tumor suppressor.
  • The role and prognostic significance of MTSS1 in GBM remain unclear.

Purpose of the Study:

  • To investigate the prognostic value of MTSS1 in GBM patients.
  • To elucidate the molecular mechanisms by which MTSS1 exerts its tumor-suppressive effects in GBM.

Main Methods:

  • Analysis of MTSS1 gene expression in GBM patient data.
  • Overexpression of MTSS1 in U-87 MG glioblastoma cell lines.
  • Assessment of cell growth, colony formation, migration, and invasion assays.
  • Evaluation of CTTN (Cortactin) expression levels.

Main Results:

  • Low MTSS1 gene expression is significantly associated with poor prognosis in GBM patients.
  • MTSS1 overexpression inhibited glioma cell proliferation, colony formation, migration, and invasion in vitro.
  • Mechanistically, high MTSS1 expression led to reduced CTTN expression in U-87 MG cells.

Conclusions:

  • MTSS1 functions as a tumor suppressor in GBM.
  • MTSS1 inhibits GBM cell migration and invasion, potentially by downregulating CTTN.
  • MTSS1 serves as a potential prognostic biomarker for GBM.

More Related Videos

Live Imaging of Microtubule Dynamics in Glioblastoma Cells Invading the Zebrafish Brain09:29

Live Imaging of Microtubule Dynamics in Glioblastoma Cells Invading the Zebrafish Brain

Published on: July 29, 2022

3.4K
Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions10:08

Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions

Published on: February 24, 2021

7.1K

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.2K